# Renal Denervation in Hypertension

Study · id `cardio:ct-nct01570777` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01570777](<https://clinicaltrials.gov/study/NCT01570777>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01570777

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

## Technical summary

Registry record NCT01570777. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 121 participants (enrolled count; ClinicalTrials.gov record NCT01570777, source copy `cardio:ctgov-nct01570777-2018-10-02`, retrieved 2026-10-26)
- Started: 2012-04 (actual) (ClinicalTrials.gov record NCT01570777, source copy `cardio:ctgov-nct01570777-2018-10-02`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01570777, source copy `cardio:ctgov-nct01570777-2018-10-02`, retrieved 2026-10-26)
- Completion: 2018-05-15 (actual) (ClinicalTrials.gov record NCT01570777, source copy `cardio:ctgov-nct01570777-2018-10-02`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT01570777, source copy `cardio:ctgov-nct01570777-2018-10-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01570777-2018-10-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Denervation in Hypertension
- Acronym: DENER-HTN
- Condition: Hypertension, Resistant to Conventional Therapy
- Condition: Renal Denervation
- Intervention (Procedure): renal denervation and optimized medication regimen
- Intervention (Procedure): optimized medication regimen
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial (`cardio:pubmed-25631070`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial (`cardio:pubmed-27576780`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension) (`cardio:pubmed-28115517`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial (`cardio:pubmed-29018027`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0790cf3819f273e0a76ed01d5877e85ef205cd9f98ee52980a09a843ba2c48cb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
